Recombinant Ephb4-Hsa Fusion Protein
Testosterone Less Than 50 ng/dL
Northwestern Universityprotein_peptidePhase 2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
17 Active assets in the Testosterone Less Than 50 ng/dL cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TESTOSTERONE UNDECYLATE University of Sao Paulo General Hospital | Phase 4 | BB |
TESTOSTERONE ENANTATE Tulane University | Phase 4 | BB |
TESTOSTERONE CIPIONATE University of Miami | Phase 4 | B |
TESTOSTERONE UNDECYLATE University of Sao Paulo General Hospital | Phase 3 | B |
CLOMIPHENE CITRATE University of Sao Paulo | Phase 2 | B |
View all 18 →
Same molecule, other indications
Recombinant Ephb4-Hsa Fusion Protein is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →